Teva in Talks to Acquire Allergan's Generic Unit

Israeli drug maker Teva Pharmaceutical is in talks to combine with Allergan’s big generic-drug business, according to people familiar with the matter. Agreement, valued at $45 billion, would give Teva largely what it was seeking from Mylan.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Teva Pharmaceutical [+]    Allergan [+]    Teva [+]    Mylan [+]   

More #news: